Important: VAERS reports alone cannot determine if a vaccine caused an adverse event. Reports may contain incomplete, inaccurate, or unverified information. Correlation does not equal causation.
#246 most reported symptom for this vaccine
Respiratory tract congestion has been reported 147 times in association with Measles, Mumps & Rubella (MMR II) vaccination in VAERS. This represents 0.2% of all 89,976 reports for this vaccine.
Among these reports, 2 mentioned death (1.36%) and 24 involved hospitalization (16.3%).
Respiratory tract congestion is the #246 most frequently reported symptom for Measles, Mumps & Rubella (MMR II) out of 2292 total symptoms.
Disclaimer: VAERS reports describe events that occurred after vaccination but do not establish that the vaccine caused the event. Many reported symptoms may be coincidental or related to underlying conditions.
Seeing 147 reports of Respiratory tract congestion after Measles, Mumps & Rubella (MMR II) vaccination may seem alarming, but context is critical.
The mortality rate of 1.36% warrants monitoring, though VAERS deaths represent temporal associations, not confirmed causal links.
This data comes from the Vaccine Adverse Event Reporting System (VAERS), jointly managed by CDC and FDA.